Rosiglitazone and cardiotoxicity--weighing the evidence

N Engl J Med. 2007 Jul 5;357(1):64-6. doi: 10.1056/NEJMe078117. Epub 2007 Jun 5.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / mortality
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Therapy, Combination
  • Heart Failure / chemically induced*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Metformin / therapeutic use
  • Rosiglitazone
  • Sulfonylurea Compounds / therapeutic use
  • Thiazolidinediones / adverse effects*

Substances

  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • Thiazolidinediones
  • Rosiglitazone
  • Metformin